Filter Results:
(2,635)
Show Results For
- All HBS Web
(2,635)
- People (1)
- News (519)
- Research (1,915)
- Events (21)
- Multimedia (35)
- Faculty Publications (936)
Show Results For
- All HBS Web
(2,635)
- People (1)
- News (519)
- Research (1,915)
- Events (21)
- Multimedia (35)
- Faculty Publications (936)
- Research Summary
Managing Customer Information
By: Frances X. Frei
After a service offering is implemented, firms routinely collect significant
amounts of data, including customer, employee, and firm financial data. However,
service firms are not nearly as effective as they could be in taking advantage
of these data. This research... View Details
- May–June 2023
- Article
The High Cost of Neglecting Low-Wage Workers: Six Mistakes That Companies Make—and How They Can Do Better
By: Joseph Fuller and Manjari Raman
Many companies blame outside factors for the trouble they’ve been having in finding and retaining frontline workers: the pandemic, the government’s stimulus checks, the intrinsic nature of low-wage work. The authors argue that in fact the real problem lies in six big... View Details
Keywords: Retention; Recruitment; Human Capital; Personal Development and Career; Compensation and Benefits; Performance Productivity
Fuller, Joseph, and Manjari Raman. "The High Cost of Neglecting Low-Wage Workers: Six Mistakes That Companies Make—and How They Can Do Better." Harvard Business Review 101, no. 3 (May–June 2023): 40–48.
- June 9, 2023
- Article
A Radical Treatment for Insulin Pricing
By: Leemore S. Dafny
In 2021, the Food and Drug Administration (FDA) approved the first interchangeable biosimilar for long-acting insulin, which many hoped would be substantially cheaper than the reference branded product. I explain why prices have barely changed, and argue that a... View Details
Keywords: Biosimilars; Rebates; Pharmaceuticals; Health Care and Treatment; Price; Governing Rules, Regulations, and Reforms; Pharmaceutical Industry; United States
Dafny, Leemore S. "A Radical Treatment for Insulin Pricing." New England Journal of Medicine 386, no. 23 (June 9, 2023): 2157–2159.
- March 2014
- Teaching Note
E-Cigarettes: Marketing Versus Public Health
By: John A. Quelch
Electronic cigarettes (e-cigarettes) were heralded by some as a healthcare game changer, enabling smokers to switch to a new product which carried lower risk of cancer. However, there were concerns about the public health risk of e-cigarettes, particularly the chance... View Details
- July–August 2012
- Article
A Better Way to Tax U.S. Businesses
By: Mihir Desai
The article argues that U.S. taxation reform should reduce corporate taxes, incorporate an awareness of the global marketplace, and generate revenue-neutral incentives for innovation. According to the article, a reduction in corporate tax rates would be offset by a tax... View Details
Keywords: Corporate Social Responsibility and Impact; Taxation; Globalization; Labor; Innovation and Invention; United States
Desai, Mihir. "A Better Way to Tax U.S. Businesses." Harvard Business Review 90, nos. 7-8 (July–August 2012): 135–139.
- 05 Nov 2014
- News
Divestment Alone Won’t Beat Climate Change
- 19 Sep 2014
- News
Peter Thiel on Why Monopolies Matter
- 12 Jan 2013
- News
In Defense of the CEO
- 28 Aug 2018
- News
Understanding Digital Strategy
- 21 Jul 2016
- News
Women More Likely Than Men To Lead In Times Of Crisis
- 2019
- Working Paper
U.S. Antitrust Law and Policy in Historical Perspective
By: Laura Phillips Sawyer
The key pieces of antitrust legislation in the United States—the Sherman Antitrust Act of 1890 and the Clayton Act of 1914—contain broad language that has afforded the courts wide latitude in interpreting and enforcing the law. This article chronicles the judiciary’s... View Details
Keywords: Antitrust; Trusts; Restraint Of Trade; Merger; Cartel; New Deal; Harvard School; Chicago School Of Law And Economics; Post-Chicago; Law; Competition; Policy; Vertical Integration; Horizontal Integration; Acquisition
Phillips Sawyer, Laura. "U.S. Antitrust Law and Policy in Historical Perspective." Harvard Business School Working Paper, No. 19-110, May 2019. (Revised September 2019.)
- December 2005
- Article
Understanding Firm, Physician and Consumer Choice Behavior in the Pharmaceutical Industry
This paper argues that the pharmaceutical industry represents an exciting opportunity to carry out academic research. The nature of the industry allows researchers to answer new questions, develop new methodologies for answering these questions as well as to apply... View Details
Manchanda, Puneet, Dick R. Wittink, Andrew Ching, Paris Cleanthous, Min Ding, Xiaojing J. Dong, Peter S. H. Leeflang, Sanjog Misra, Natalie Mizik, Sridhar Narayanan, Thomas J. Steenburgh, Jaap E. Wieringa, Marta Wosinska, and Ying Xie. "Understanding Firm, Physician and Consumer Choice Behavior in the Pharmaceutical Industry." Marketing Letters 16, nos. 3/4 (December 2005): 293 – 308.
- May 1994
- Background Note
Managing Market Complexity: A Three-Ring Circus
Proposes models of organization that address the various product-market environments posed by the product life cycle. Frames these changes along the two dimensions of uncertainty and diversity. Offers three sets of organizational characteristics to reflect the three... View Details
Keywords: Business Processes; Growth and Development Strategy; Complexity; Organizational Structure; Organizational Culture; Product Marketing; Markets; Product
Rangan, V. Kasturi. "Managing Market Complexity: A Three-Ring Circus." Harvard Business School Background Note 594-119, May 1994.
- 02 May 2022
- News
Spotify, Disney, Ukraine, and Deep Purpose (ft. Ranjay Gulati)
- February 2018
- Case
Road Rage at the DMV
By: Andrew Wasynczuk, Katherine Baldiga Coffman and Karim Sameh
When Hewlett-Packard Enterprise notified the Rhode Island's Governor's Office that it wouldn't be able to deliver a "fully-functioning" technology upgrade for the Department of Motor Vehicles, both parties had reached a breaking point. While HPE argued that it would... View Details
Keywords: Department Of Motor Vehicles; Hewlett Packard; Hewlett Packard Enterprise; HP; HPE; Dispute Resolution; Litigation; Governor; Government; Dispute; Negotiation Process; Conflict and Resolution; Negotiation; Government and Politics; Technology Industry; Rhode Island
Wasynczuk, Andrew, Katherine Baldiga Coffman, and Karim Sameh. "Road Rage at the DMV." Harvard Business School Case 918-013, February 2018.
A Radical Treatment for Insulin Pricing
In 2021, the Food and Drug Administration (FDA) approved the first interchangeable biosimilar for long-acting insulin, which many hoped would be substantially cheaper than the reference branded product. I explain why prices have barely changed, and argue that a... View Details
- June 2024 (Revised January 2025)
- Background Note
Politics Comes to ESG Investing
By: Shawn Cole and Jonah Zahnd
While the past decade has seen a dramatic increase in the incorporation of Environmental, Social and Governance (ESG) standards into investor practices, this momentum has shifted recently in the United States, as some politicians argued that ESG investing practices... View Details
Cole, Shawn, and Jonah Zahnd. "Politics Comes to ESG Investing." Harvard Business School Background Note 224-107, June 2024. (Revised January 2025.)
- January 1993 (Revised October 1994)
- Background Note
Note on Adjusted Present Value
By: Timothy A. Luehrman
Describes the "adjusted present value" (APV) approach to discounted cash flow analysis. Much of the note is devoted to a critical comparison of APV and an approach based on the wrighted average cost of capital (WACC). Argues that APV is usually, if not always, simpler,... View Details
Luehrman, Timothy A. "Note on Adjusted Present Value." Harvard Business School Background Note 293-092, January 1993. (Revised October 1994.)
- 16 Mar 2021
- News